Vitali Boitsov

Dr. Vitali Boitsov

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2017 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
AFAlexander S. Filatov
Alexander S. Filatov
NKNickolay A. Knyazev
Nickolay A. Knyazev
AMAlexander P. Molchanov
Alexander P. Molchanov
Taras Leonidovich PanikorovskiiTaras Leonidovich Panikorovskii
Taras Leonidovich Panikorovskii
RKRafael R. Kostikov
Rafael R. Kostikov
ASAlexander V. Stepakov
Alexander V. Stepakov

9 October 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
ABAlexey A. Belogurov
Alexey A. Belogurov
ASAlexey V. Stepanov
Alexey V. Stepanov
ISIvan V. Smirnov
Ivan V. Smirnov
DMDobroslav Melamed
Dobroslav Melamed
ABAndrew Bacon
Andrew Bacon
AGAlexander Gabibov
Alexander Gabibov
Multiple sclerosis (MS) is a severe inflammatory and neurodegenerative disease with an autoimmune background. Despite the variety of therapeutics available against MS, the development of novel approaches to its treatment is of high importance in modern pharmaceutics. In this study, experimental autoimmune encephalomyelitis (EAE) in Dark Agouti rats has been treated with immunodominant peptides of the myelin basic protein (MBP) encapsulated in mannosylated small unilamellar vesicles. The results show that liposome‐encapsulated MBP 46–62 is the most effective in reducing maximal disease score during the first attack, while MBP 124–139 and MBP 147–170 can completely prevent the development of the exacerbation stage. Both mannosylation of liposomes and encapsulation of peptides are critical for the therapeutic effect, since neither naked peptides nor nonmannosylated liposomes, loaded or empty, have proved effective. The liposome‐mediated synergistic effect of the mixture of 3 MBP peptides significantly suppresses the progression of protracted EAE, with the median cumulative disease score being reduced from 22 to 14 points, compared to the placebo group; prevents the production of circulating autoantibodies; down‐regulates the synthesis of Th1 cytokines; and induces the production of brain‐derived neurotrophic factor in the central nervous system. Thus, the proposed formulation ameliorates EAE, providing for a less severe first attack and rapid recovery from exacerbation, and offers a promising therapeutic modality in MS treatment.—Belogurov, A. A., Jr., Stepanov, A. V., Smirnov, I. V., Melamed, D., Bacon, A., Mamedov, A. E., Boitsov, V. M., Sashchenko, L. P., Ponomarenko, N. A., Sharanova, S. N., Boyko, A. N., Dubina, M. V., Friboulet, A., Genkin, D. D., Gabibov, A. G. Liposome‐encapsulated peptides protect against experimental allergic encephalitis. FASEB J. 27, 222–231 (2013). www.fasebj.org

12 July 2010 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
SSSergey Sergeyev
Sergey Sergeyev
DDDelphine Didier
Delphine Didier
VBVitali Boitsov
Vitali Boitsov
ATAyele Teshome
Ayele Teshome
IAInge Asselberghs
Inge Asselberghs
Benoit CHAMPAGNEBenoit CHAMPAGNE
Benoit CHAMPAGNE

1 November 2017 in Organic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
AFA. S. Filatov
A. S. Filatov
NKNickolay A. Knyazev
Nickolay A. Knyazev
Mikhail N RyazantsevMikhail N Ryazantsev
Mikhail N Ryazantsev
VSV. V. Suslonov
V. V. Suslonov
ALA. G. Larina
A. G. Larina
ASA. V. Stepakov
A. V. Stepakov
A simple and efficient method has been developed for the synthesis of complex compounds with spiro-fused 11H-indeno[1,2-b]quinoxaline and cyclopropa[a]pyrrolizine or azabicyclo[3.1.0]hexane moieties. All the products have been synthesized in good to high yields and excellent diastereoselectivity by one-pot three-component 1,3-dipolar cycloaddition reactions of various derivatives of cyclopropene with azomethine ylides. Azomethine ylides were in situ generated from 11H-indeno[1,2-b]quinoxalin-11-one derivatives and amines, such as N-substituted and N-unsubstituted α-amino acids, benzylamines, and also peptides (dipeptide Gly-Gly and tripeptide Gly-Gly-Gly). To understand the mechanism that allows for azomethine ylide generation followed by 1,3-dipolar cycloaddition, a quantum chemical investigation was performed. The anticancer activity of some of the obtained compounds against the human leukemia K562 cell line was evaluated by flow cytometry in vitro.

8 May 2019 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
AFAlexander S. Filatov
Alexander S. Filatov
SWSiqi Wang
Siqi Wang
OKOlesya V. Khoroshilova
Olesya V. Khoroshilova
SLStanislav V. Lozovskiy
Stanislav V. Lozovskiy
ALAnna G. Larina
Anna G. Larina
ASAlexander V. Stepakov
Alexander V. Stepakov

10 October 2018 in Synthesis
Verified
Journal Article
Closed access
PDF file
VBVitali Boitsov
Vitali Boitsov
ASAlexander V. Stepakov
Alexander V. Stepakov
AFAlexander S. Filatov
Alexander S. Filatov
NKNickolay A. Knyazev
Nickolay A. Knyazev
SSStanislav V. Shmakov
Stanislav V. Shmakov
ALAnna G. Larina
Anna G. Larina
A simple, efficient and atom-economic method has been developed for the synthesis of complex alkaloid-like compounds with spiro-fused indolo[2,1-b]quinazoline and cyclopropa[a]pyrrolizine or 3-azabicyclo[3.1.0]hexane moieties. We have found that one-pot, three-component 1,3-dipolar cycloaddition reactions allow the desired products to be obtained from various cyclopropene derivatives with tryptanthrin-derived azomethine ylides generated in situ, in good to high yields and excellent diastereoselectivity. The possibility of ylide generation was exemplified by using α-amino acids (l-proline, l-4-thiazolidincarboxylic acid) and simplest peptides (dipeptide Gly-Gly, tripeptide Gly-Gly-Gly). Quantum chemical investigations indicate that the reaction proceeds through the S-shaped azomethine ylide, the interaction of which with cyclopropenes proceeds via a less sterically hindered endo-transition state. The antitumor activity of some of spiro-tryptanthrin derivatives against erythroleukemia (K562), cervical carcinoma (HeLa) and colon carcinoma (CT26) cell lines was evaluated in vitro by MTS-assay.